Ibyerekeye-kanseri / kuvura / ibiyobyabwenge / igifu

Ibiyobyabwenge Byemewe Kanseri Yinda (Gastric)

Uru rupapuro rugaragaza imiti ya kanseri yemejwe n’ubuyobozi bushinzwe ibiryo n'ibiyobyabwenge (FDA) kuri kanseri yo mu gifu (gastric). Urutonde rurimo amazina rusange nibiranga. Uru rupapuro kandi rugaragaza urutonde rwibiyobyabwenge bikoreshwa muri kanseri yigifu (gastric). Ibiyobyabwenge kugiti cye hamwe byemewe na FDA. Nyamara, guhuza ibiyobyabwenge ubwabyo mubisanzwe ntabwo byemewe, nubwo bikoreshwa cyane.

Amazina yibiyobyabwenge ahuza incamake yamakuru ya Kanseri ya NCI. Hashobora kuba hari imiti ikoreshwa muri kanseri yo mu gifu (gastric) itanditswe hano.

KURI URUPAPURO

• Ibiyobyabwenge Byemewe Kanseri Yinda (Gastric)

• Kunywa ibiyobyabwenge bikoreshwa muri Kanseri yo mu gifu (Gastric)

• Ibiyobyabwenge Byemewe kuri Gastroenteropancreatic Neuroendocrine Tumors

Ibiyobyabwenge Byemewe Kanseri Yinda (Gastric)

Cyramza (Ramucirumab)

Inyandiko

Doxorubicin Hydrochloride

5-FU (Injiza ya Fluorouracil)

Injiza ya Fluorouracil

Herceptin (Trastuzumab)

Keytruda (Pembrolizumab)

Lonsurf (Trifluridine na Tipiracil Hydrochloride)

Mitomycin C.

Pembrolizumab

Ramucirumab

Tagisi (Docetaxel)

Trastuzumab

Trifluridine na Tipiracil Hydrochloride

Kunywa ibiyobyabwenge bikoreshwa muri Kanseri yo mu gifu (Gastric)

FU-LV

TPF

XELIRI

Ibiyobyabwenge Byemewe kuri Gastroenteropancreatic Neuroendocrine Tumors

Afinitor (Everolimus)

Afinitor Disperz (Everolimus)

Everolimus

Lanreotide Acetate

Depot ya Somatuline (Lanreotide Acetate)